跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SLYND - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SLYND
Authorized
STANDARD
SLYND
Duchesnay Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5d4320d04422a1f8
Company
Duchesnay Inc
Type
Standard
Approval Details
Approval Id
5d4320d04422a1f8
Drug Approval Canada Name
SLYND
Product Name
SLYND
Status
Marketed
Status Date
2022-04-20
Original Market Date
2022-04-20
Din
02522802
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:12.00
Atc Original
G03AC10 DROSPIRENONE
Atc Name
g 03 ac 10
Aig Number
0163280001
Company Name
Duchesnay Inc
Company Address
950 Michele-Bohec Blvd, Blainville, Quebec, Canada, J7C 5E2
Company Detail Path
/organization/duchesnay-inc
Company Information
Pharmaceutical Company Name
Duchesnay Inc
Country Name
Canada
Province Name
Quebec
City Name
blainville,quebec,country_ca
Address
950 boul Michèle-Bohec
Active Ingredients
DROSPIRENONE
4 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5d4320d04422a1f8
Type
Standard
Back to Health Canada Approvals